Imiquimod Cream 3.75%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imiquimod Cream 3.75%, covering 2014-01-22 to 2014-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis. [Phase 1]